Free Trial
NASDAQ:NOVT

Novanta Q3 2026 Earnings Report

Novanta logo
$150.61 +1.34 (+0.90%)
Closing price 04:00 PM Eastern
Extended Trading
$149.16 -1.46 (-0.97%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Novanta EPS Results

Actual EPS
N/A
Consensus EPS
$0.97
Beat/Miss
N/A
One Year Ago EPS
N/A

Novanta Revenue Results

Actual Revenue
N/A
Expected Revenue
$301.02 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Novanta Announcement Details

Quarter
Q3 2026
Time
Before Market Opens
Conference Call Date
Tuesday, November 3, 2026
Conference Call Time
8:30AM ET

Conference Call Resources

Novanta Earnings Headlines

Ticker Revealed: Pre-IPO Access to "Next Elon Musk" Company
We’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it.tc pixel
See More Novanta Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Novanta? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Novanta and other key companies, straight to your email.

About Novanta

Novanta (NASDAQ:NOVT) (NASDAQ:NOVT) is a medical technology and advanced equipment company that develops components and subsystems used by original equipment manufacturers. Its technologies are designed for applications requiring precision motion, photonics, imaging, and other specialized capabilities, with a primary focus on healthcare and medical device markets.

The company’s offerings include precision motion control systems, motors, pumps, encoders, laser sources, optical components, and beam-delivery systems. Novanta also provides medical technologies such as surgical visualization and imaging systems, insufflation equipment, fluid-management products, and other components used in minimally invasive and robotic-assisted procedures.

Novanta serves medical device and industrial customers internationally, with operations and customer relationships spanning North America, Europe, and Asia. The company traces its history to businesses established in the late 1960s and adopted the Novanta name in 2016 after operating as GSI Group. Novanta is led by Chief Executive Officer Matthijs Glastra.

View Novanta Profile